Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
Simon Guiraud, Benjamin Edwards, Arran Babbs, et al.
Human Molecular Genetics (2019) Vol. 28, Iss. 13, pp. 2189-2200
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

Therapeutic approaches for Duchenne muscular dystrophy
Thomas C. Roberts, Matthew J. A. Wood, Kay E. Davies
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 11, pp. 917-934
Closed Access | Times Cited: 60
Muscle spindle function in healthy and diseased muscle
Stephan Kröger, Bridgette Watkins
Skeletal Muscle (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 87
Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future
Agnieszka Łoboda, Józef Dulak
Pharmacological Reports (2020) Vol. 72, Iss. 5, pp. 1227-1263
Open Access | Times Cited: 65
Current Pharmacological Strategies for Duchenne Muscular Dystrophy
Shanshan Yao, Zihao Chen, Liang Yu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 49
CRISPR technologies for the treatment of Duchenne muscular dystrophy
Eunyoung Choi, Taeyoung Koo
Molecular Therapy (2021) Vol. 29, Iss. 11, pp. 3179-3191
Open Access | Times Cited: 45
CRISPR-Editing Therapy for Duchenne Muscular Dystrophy
Francesco Chemello, Eric N. Olson, Rhonda Bassel‐Duby
Human Gene Therapy (2023) Vol. 34, Iss. 9-10, pp. 379-387
Open Access | Times Cited: 18
Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy
Anna Rugowska, Alicja Starosta, Patryk Konieczny
Clinical Epigenetics (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 41
Evaluating the potential of novel genetic approaches for the treatment of Duchenne muscular dystrophy
Vratko Himič, Kay E. Davies
European Journal of Human Genetics (2021) Vol. 29, Iss. 9, pp. 1369-1376
Open Access | Times Cited: 35
The multifaceted view of heart problem in Duchenne muscular dystrophy
Urszula Florczyk, Katarzyna Polak, Józef Dulak
Cellular and Molecular Life Sciences (2021)
Open Access | Times Cited: 35
Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies
Patricia Soblechero‐Martín, Andrea López‐Martínez, Laura de la Puente Ovejero, et al.
Neuropathology and Applied Neurobiology (2021) Vol. 47, Iss. 6, pp. 711-723
Open Access | Times Cited: 30
Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy
Alicja Starosta, Patryk Konieczny
Cellular and Molecular Life Sciences (2021) Vol. 78, Iss. 11, pp. 4867-4891
Open Access | Times Cited: 27
Dystrophin- and Utrophin-Based Therapeutic Approaches for Treatment of Duchenne Muscular Dystrophy: A Comparative Review
Sylwia Szwec, Zuzanna Kapłucha, Jeffrey S. Chamberlain, et al.
BioDrugs (2023) Vol. 38, Iss. 1, pp. 95-119
Open Access | Times Cited: 10
From diagnosis to therapy in Duchenne muscular dystrophy
Arran Babbs, Maria Chatzopoulou, Ben Edwards, et al.
Biochemical Society Transactions (2020) Vol. 48, Iss. 3, pp. 813-821
Open Access | Times Cited: 25
MuscleJ2: a rebuilding of MuscleJ with new features for high-content analysis of skeletal muscle immunofluorescence slides
Anne Danckaert, Aurélie Trignol, Guillaume Le Loher, et al.
Skeletal Muscle (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Absence of Significant Off-Target Splicing Variation with a U7snRNA Vector Targeting DMD Exon 2 Duplications
Nicolas Wein, Diane M. Dunn, Megan A. Waldrop, et al.
Human Gene Therapy (2021)
Closed Access | Times Cited: 15
Hydrogen sulfide as a therapeutic option for the treatment of Duchenne muscular dystrophy and other muscle-related diseases
Katarzyna Kaziród, Małgorzata Myszka, Józef Dulak, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 12
Open Access | Times Cited: 11
Gene therapy delivered micro-dystrophins co-localize with transgenic utrophin in dystrophic skeletal muscle fibers
Swathy Krishna, Arden B. Piepho, Dana M. Lake, et al.
Neuromuscular Disorders (2024) Vol. 36, pp. 1-5
Open Access | Times Cited: 2
Satellite cell-derived TRIM28 is pivotal for mechanical load- and injury-induced myogenesis
Kuan‐Hung Lin, Jamie E. Hibbert, Corey Flynn, et al.
EMBO Reports (2024) Vol. 25, Iss. 9, pp. 3812-3841
Open Access | Times Cited: 2
Impaired muscle spindle function in murine models of muscular dystrophy
Laura Gerwin, Sarah Rossmanith, Corinna Haupt, et al.
The Journal of Physiology (2020) Vol. 598, Iss. 8, pp. 1591-1609
Open Access | Times Cited: 15
Rapid, redox-mediated mechanical susceptibility of the cortical microtubule lattice in skeletal muscle
D’anna M. Nelson, Elizabeth K. Fasbender, Margurite C. Jakubiak, et al.
Redox Biology (2020) Vol. 37, pp. 101730-101730
Open Access | Times Cited: 15
Synthesis of SMT022357 enantiomers and in vivo evaluation in a Duchenne muscular dystrophy mouse model
Arran Babbs, Adam Berg, Maria Chatzopoulou, et al.
Tetrahedron (2019) Vol. 76, Iss. 2, pp. 130819-130819
Open Access | Times Cited: 15
Restoration of Functional Full-Length Dystrophin After Intramuscular Transplantation of Foamy Virus-Transduced Myoblasts
Jinhong Meng, Nathan P. Sweeney, Bruno Doreste, et al.
Human Gene Therapy (2019) Vol. 31, Iss. 3-4, pp. 241-252
Open Access | Times Cited: 12
Hypoxia treatment and resistance training alters microRNA profiling in rats skeletal muscle
Tao Mei, Yang Hu, Ying Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Myoblast-derived ADAMTS-like 2 promotes skeletal muscle regeneration after injury
Nandaraj Taye, L. Medina Rodríguez, James C. Iatridis, et al.
npj Regenerative Medicine (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Surrogate gene therapy for muscular dystrophy
Kay E. Davies, Jeffrey S. Chamberlain
Nature Medicine (2019) Vol. 25, Iss. 10, pp. 1473-1474
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top